Report Detail

Medical Devices & Consumables Global Coronavirus Disease 2019 Test Kit Market Research Report 2021

  • RnM4302033
  • |
  • 06 April, 2021
  • |
  • Global
  • |
  • 130 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Nucleic Acid Test Kit
Antibody Test Kit

Segment by Application
Hospital
Scientific Research
Diagnostic Center

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Thermo Fisher Scientific
LabCorp
Cepheid
Hologic
Danaher
Roche Diagnostics
BioMérieux
Integrated DNA Technologies
Abbott Laboratories
Beijing Genomics Institute
Shanghai Huirui Biotechnology
Geneodx
Shanghai BioGerm Medical Biotechnology
Da An Gene
Wondfo
INNOVITA
Kogenebiotech
Mylab Discovery
Altona Diagnostics
Seegene
SD Biosensor
Biomaxima
Quidel
Qiagen
GenMark Diagnostics


1 Coronavirus Disease 2019 Test Kit Market Overview

  • 1.1 Product Overview and Scope of Coronavirus Disease 2019 Test Kit
  • 1.2 Coronavirus Disease 2019 Test Kit Segment by Type
    • 1.2.1 Global Coronavirus Disease 2019 Test Kit Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Nucleic Acid Test Kit
    • 1.2.3 Antibody Test Kit
  • 1.3 Coronavirus Disease 2019 Test Kit Segment by Application
    • 1.3.1 Coronavirus Disease 2019 Test Kit Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Scientific Research
    • 1.3.4 Diagnostic Center
  • 1.4 Global Coronavirus Disease 2019 Test Kit Market Size Estimates and Forecasts
    • 1.4.1 Global Coronavirus Disease 2019 Test Kit Revenue 2016-2027
    • 1.4.2 Global Coronavirus Disease 2019 Test Kit Sales 2016-2027
    • 1.4.3 Coronavirus Disease 2019 Test Kit Market Size by Region: 2016 Versus 2021 Versus 2027

2 Coronavirus Disease 2019 Test Kit Market Competition by Manufacturers

  • 2.1 Global Coronavirus Disease 2019 Test Kit Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Coronavirus Disease 2019 Test Kit Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Coronavirus Disease 2019 Test Kit Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Coronavirus Disease 2019 Test Kit Manufacturing Sites, Area Served, Product Type
  • 2.5 Coronavirus Disease 2019 Test Kit Market Competitive Situation and Trends
    • 2.5.1 Coronavirus Disease 2019 Test Kit Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Coronavirus Disease 2019 Test Kit Players Market Share by Revenue
    • 2.5.3 Global Coronavirus Disease 2019 Test Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Coronavirus Disease 2019 Test Kit Retrospective Market Scenario by Region

  • 3.1 Global Coronavirus Disease 2019 Test Kit Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Coronavirus Disease 2019 Test Kit Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Coronavirus Disease 2019 Test Kit Market Facts & Figures by Country
    • 3.3.1 North America Coronavirus Disease 2019 Test Kit Sales by Country
    • 3.3.2 North America Coronavirus Disease 2019 Test Kit Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Coronavirus Disease 2019 Test Kit Market Facts & Figures by Country
    • 3.4.1 Europe Coronavirus Disease 2019 Test Kit Sales by Country
    • 3.4.2 Europe Coronavirus Disease 2019 Test Kit Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Coronavirus Disease 2019 Test Kit Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Coronavirus Disease 2019 Test Kit Sales by Region
    • 3.5.2 Asia Pacific Coronavirus Disease 2019 Test Kit Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Coronavirus Disease 2019 Test Kit Market Facts & Figures by Country
    • 3.6.1 Latin America Coronavirus Disease 2019 Test Kit Sales by Country
    • 3.6.2 Latin America Coronavirus Disease 2019 Test Kit Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Coronavirus Disease 2019 Test Kit Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Coronavirus Disease 2019 Test Kit Sales by Country
    • 3.7.2 Middle East and Africa Coronavirus Disease 2019 Test Kit Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Coronavirus Disease 2019 Test Kit Historic Market Analysis by Type

  • 4.1 Global Coronavirus Disease 2019 Test Kit Sales Market Share by Type (2016-2021)
  • 4.2 Global Coronavirus Disease 2019 Test Kit Revenue Market Share by Type (2016-2021)
  • 4.3 Global Coronavirus Disease 2019 Test Kit Price by Type (2016-2021)

5 Global Coronavirus Disease 2019 Test Kit Historic Market Analysis by Application

  • 5.1 Global Coronavirus Disease 2019 Test Kit Sales Market Share by Application (2016-2021)
  • 5.2 Global Coronavirus Disease 2019 Test Kit Revenue Market Share by Application (2016-2021)
  • 5.3 Global Coronavirus Disease 2019 Test Kit Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Thermo Fisher Scientific
    • 6.1.1 Thermo Fisher Scientific Corporation Information
    • 6.1.2 Thermo Fisher Scientific Description and Business Overview
    • 6.1.3 Thermo Fisher Scientific Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Thermo Fisher Scientific Product Portfolio
    • 6.1.5 Thermo Fisher Scientific Recent Developments/Updates
  • 6.2 LabCorp
    • 6.2.1 LabCorp Corporation Information
    • 6.2.2 LabCorp Description and Business Overview
    • 6.2.3 LabCorp Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 LabCorp Product Portfolio
    • 6.2.5 LabCorp Recent Developments/Updates
  • 6.3 Cepheid
    • 6.3.1 Cepheid Corporation Information
    • 6.3.2 Cepheid Description and Business Overview
    • 6.3.3 Cepheid Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Cepheid Product Portfolio
    • 6.3.5 Cepheid Recent Developments/Updates
  • 6.4 Hologic
    • 6.4.1 Hologic Corporation Information
    • 6.4.2 Hologic Description and Business Overview
    • 6.4.3 Hologic Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Hologic Product Portfolio
    • 6.4.5 Hologic Recent Developments/Updates
  • 6.5 Danaher
    • 6.5.1 Danaher Corporation Information
    • 6.5.2 Danaher Description and Business Overview
    • 6.5.3 Danaher Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Danaher Product Portfolio
    • 6.5.5 Danaher Recent Developments/Updates
  • 6.6 Roche Diagnostics
    • 6.6.1 Roche Diagnostics Corporation Information
    • 6.6.2 Roche Diagnostics Description and Business Overview
    • 6.6.3 Roche Diagnostics Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Roche Diagnostics Product Portfolio
    • 6.6.5 Roche Diagnostics Recent Developments/Updates
  • 6.7 BioMérieux
    • 6.6.1 BioMérieux Corporation Information
    • 6.6.2 BioMérieux Description and Business Overview
    • 6.6.3 BioMérieux Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 BioMérieux Product Portfolio
    • 6.7.5 BioMérieux Recent Developments/Updates
  • 6.8 Integrated DNA Technologies
    • 6.8.1 Integrated DNA Technologies Corporation Information
    • 6.8.2 Integrated DNA Technologies Description and Business Overview
    • 6.8.3 Integrated DNA Technologies Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Integrated DNA Technologies Product Portfolio
    • 6.8.5 Integrated DNA Technologies Recent Developments/Updates
  • 6.9 Abbott Laboratories
    • 6.9.1 Abbott Laboratories Corporation Information
    • 6.9.2 Abbott Laboratories Description and Business Overview
    • 6.9.3 Abbott Laboratories Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Abbott Laboratories Product Portfolio
    • 6.9.5 Abbott Laboratories Recent Developments/Updates
  • 6.10 Beijing Genomics Institute
    • 6.10.1 Beijing Genomics Institute Corporation Information
    • 6.10.2 Beijing Genomics Institute Description and Business Overview
    • 6.10.3 Beijing Genomics Institute Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Beijing Genomics Institute Product Portfolio
    • 6.10.5 Beijing Genomics Institute Recent Developments/Updates
  • 6.11 Shanghai Huirui Biotechnology
    • 6.11.1 Shanghai Huirui Biotechnology Corporation Information
    • 6.11.2 Shanghai Huirui Biotechnology Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.11.3 Shanghai Huirui Biotechnology Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Shanghai Huirui Biotechnology Product Portfolio
    • 6.11.5 Shanghai Huirui Biotechnology Recent Developments/Updates
  • 6.12 Geneodx
    • 6.12.1 Geneodx Corporation Information
    • 6.12.2 Geneodx Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.12.3 Geneodx Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Geneodx Product Portfolio
    • 6.12.5 Geneodx Recent Developments/Updates
  • 6.13 Shanghai BioGerm Medical Biotechnology
    • 6.13.1 Shanghai BioGerm Medical Biotechnology Corporation Information
    • 6.13.2 Shanghai BioGerm Medical Biotechnology Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.13.3 Shanghai BioGerm Medical Biotechnology Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Shanghai BioGerm Medical Biotechnology Product Portfolio
    • 6.13.5 Shanghai BioGerm Medical Biotechnology Recent Developments/Updates
  • 6.14 Da An Gene
    • 6.14.1 Da An Gene Corporation Information
    • 6.14.2 Da An Gene Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.14.3 Da An Gene Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Da An Gene Product Portfolio
    • 6.14.5 Da An Gene Recent Developments/Updates
  • 6.15 Wondfo
    • 6.15.1 Wondfo Corporation Information
    • 6.15.2 Wondfo Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.15.3 Wondfo Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Wondfo Product Portfolio
    • 6.15.5 Wondfo Recent Developments/Updates
  • 6.16 INNOVITA
    • 6.16.1 INNOVITA Corporation Information
    • 6.16.2 INNOVITA Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.16.3 INNOVITA Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 INNOVITA Product Portfolio
    • 6.16.5 INNOVITA Recent Developments/Updates
  • 6.17 Kogenebiotech
    • 6.17.1 Kogenebiotech Corporation Information
    • 6.17.2 Kogenebiotech Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.17.3 Kogenebiotech Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Kogenebiotech Product Portfolio
    • 6.17.5 Kogenebiotech Recent Developments/Updates
  • 6.18 Mylab Discovery
    • 6.18.1 Mylab Discovery Corporation Information
    • 6.18.2 Mylab Discovery Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.18.3 Mylab Discovery Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Mylab Discovery Product Portfolio
    • 6.18.5 Mylab Discovery Recent Developments/Updates
  • 6.19 Altona Diagnostics
    • 6.19.1 Altona Diagnostics Corporation Information
    • 6.19.2 Altona Diagnostics Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.19.3 Altona Diagnostics Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Altona Diagnostics Product Portfolio
    • 6.19.5 Altona Diagnostics Recent Developments/Updates
  • 6.20 Seegene
    • 6.20.1 Seegene Corporation Information
    • 6.20.2 Seegene Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.20.3 Seegene Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Seegene Product Portfolio
    • 6.20.5 Seegene Recent Developments/Updates
  • 6.21 SD Biosensor
    • 6.21.1 SD Biosensor Corporation Information
    • 6.21.2 SD Biosensor Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.21.3 SD Biosensor Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 SD Biosensor Product Portfolio
    • 6.21.5 SD Biosensor Recent Developments/Updates
  • 6.22 Biomaxima
    • 6.22.1 Biomaxima Corporation Information
    • 6.22.2 Biomaxima Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.22.3 Biomaxima Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.22.4 Biomaxima Product Portfolio
    • 6.22.5 Biomaxima Recent Developments/Updates
  • 6.23 Quidel
    • 6.23.1 Quidel Corporation Information
    • 6.23.2 Quidel Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.23.3 Quidel Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.23.4 Quidel Product Portfolio
    • 6.23.5 Quidel Recent Developments/Updates
  • 6.24 Qiagen
    • 6.24.1 Qiagen Corporation Information
    • 6.24.2 Qiagen Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.24.3 Qiagen Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.24.4 Qiagen Product Portfolio
    • 6.24.5 Qiagen Recent Developments/Updates
  • 6.25 GenMark Diagnostics
    • 6.25.1 GenMark Diagnostics Corporation Information
    • 6.25.2 GenMark Diagnostics Coronavirus Disease 2019 Test Kit Description and Business Overview
    • 6.25.3 GenMark Diagnostics Coronavirus Disease 2019 Test Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.25.4 GenMark Diagnostics Product Portfolio
    • 6.25.5 GenMark Diagnostics Recent Developments/Updates

7 Coronavirus Disease 2019 Test Kit Manufacturing Cost Analysis

  • 7.1 Coronavirus Disease 2019 Test Kit Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Coronavirus Disease 2019 Test Kit
  • 7.4 Coronavirus Disease 2019 Test Kit Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Coronavirus Disease 2019 Test Kit Distributors List
  • 8.3 Coronavirus Disease 2019 Test Kit Customers

9 Coronavirus Disease 2019 Test Kit Market Dynamics

  • 9.1 Coronavirus Disease 2019 Test Kit Industry Trends
  • 9.2 Coronavirus Disease 2019 Test Kit Growth Drivers
  • 9.3 Coronavirus Disease 2019 Test Kit Market Challenges
  • 9.4 Coronavirus Disease 2019 Test Kit Market Restraints

10 Global Market Forecast

  • 10.1 Coronavirus Disease 2019 Test Kit Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Coronavirus Disease 2019 Test Kit by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Coronavirus Disease 2019 Test Kit by Type (2022-2027)
  • 10.2 Coronavirus Disease 2019 Test Kit Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Coronavirus Disease 2019 Test Kit by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Coronavirus Disease 2019 Test Kit by Application (2022-2027)
  • 10.3 Coronavirus Disease 2019 Test Kit Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Coronavirus Disease 2019 Test Kit by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Coronavirus Disease 2019 Test Kit by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    Summary:
    Get latest Market Research Reports on Coronavirus Disease 2019 Test Kit. Industry analysis & Market Report on Coronavirus Disease 2019 Test Kit is a syndicated market report, published as Global Coronavirus Disease 2019 Test Kit Market Research Report 2021. It is complete Research Study and Industry Analysis of Coronavirus Disease 2019 Test Kit market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,328.70
    3,493.05
    4,657.40
    2,720.20
    4,080.30
    5,440.40
    447,847.00
    671,770.50
    895,694.00
    242,556.00
    363,834.00
    485,112.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report